-
1دورية أكاديمية
المؤلفون: Donnelly, Louise A., Dennis, John M., Coleman, Ruth L., Sattar, Naveed, Hattersley, Andrew T., Holman, Rury R., Pearson, Ewan R.
المصدر: Diabetes Care; Oct2020, Vol. 43 Issue 10, p2493-2499, 7p
مصطلحات موضوعية: TYPE 2 diabetes, METFORMIN, ANEMIA, VITAMIN B12, FAILURE analysis, RESEARCH, CLINICAL trials, CHAOS theory, RESEARCH methodology, ACQUISITION of data, SULFONYLUREAS, HYPOGLYCEMIC agents, MEDICAL cooperation, EVALUATION research, INSULIN, COMPARATIVE studies, THIAZOLIDINEDIONES, LONGITUDINAL method
-
2دورية أكاديمية
المؤلفون: Reed, Shelby D., Yanhong Li, Dakin, Helen A., Becker, Frauke, Leal, Jose, Gustavson, Stephanie M., Kartman, Bernt, Wittbrodt, Eric, Mentz, Robert J., Pagidipati, Neha J., Bethel, M. Angelyn, Gray, Alastair M., Holman, Rury R., Li, Yanhong, Hernandez, Adrian F, EXSCEL Study Group
المصدر: Diabetes Care; Feb2020, Vol. 43 Issue 2, p374-381, 8p, 2 Charts, 2 Graphs
مصطلحات موضوعية: TYPE 2 diabetes, CARDIOVASCULAR diseases, QUALITY of life, COST, MEDICAL care cost statistics, ECONOMIC impact, CARDIOVASCULAR disease prevention, CAUSES of death, RESEARCH, FERRANS & Powers Quality of Life Index, CLINICAL trials, RESEARCH methodology, HYPOGLYCEMIC agents, DISEASE incidence, EVALUATION research, MEDICAL cooperation, MEDICAL care use, COMPARATIVE studies, HOSPITAL care, RESEARCH funding, QUESTIONNAIRES, MEDICARE, DIABETIC angiopathies, LONGITUDINAL method, ECONOMICS, DISEASE complications
مصطلحات جغرافية: UNITED States
-
3دورية أكاديمية
المؤلفون: Bethel, M. Angelyn, Engel, Samuel S., Green, Jennifer B., Zhen Huang, Josse, Robert G., Kaufman, Keith D., Standl, Eberhard, Suryawanshi, Shailaja, Van de Werf, Frans, McGuire, Darren K., Peterson, Eric D., Holman, Rury R., Huang, Zhen, TECOS Study Group
المصدر: Diabetes Care; Apr2017, Vol. 40 Issue 4, p494-501, 8p, 4 Charts, 1 Graph
مصطلحات موضوعية: SITAGLIPTIN, DRUG efficacy, TYPE 2 diabetes treatment, DIABETES in old age, HYPOGLYCEMIC agents, THERAPEUTICS, COMPARATIVE studies, GLYCOSYLATED hemoglobin, HYPOGLYCEMIA, LONGITUDINAL method, RESEARCH methodology, MEDICAL cooperation, MYOCARDIAL infarction, TYPE 2 diabetes, RESEARCH, STATISTICAL sampling, STROKE, EVALUATION research, BODY mass index, RANDOMIZED controlled trials, TREATMENT effectiveness, BLIND experiment
-
4دورية أكاديمية
المؤلفون: Farmer, Andrew J., Rodgers, Lauren R., Lonergan, Mike, Shields, Beverley, Weedon, Michael N., Donnelly, Louise, Holman, Rury R., Pearson, Ewan R., Hattersley, Andrew T., MASTERMIND Consortium
المصدر: Diabetes Care; Feb2016, Vol. 39 Issue 2, p258-263, 6p, 2 Charts, 1 Graph
مصطلحات موضوعية: PATIENT compliance, HYPOGLYCEMIC agents, GLYCOSYLATED hemoglobin, PRIMARY care, TYPE 2 diabetes treatment, THERAPEUTIC use of protease inhibitors, SULFONYLUREAS, METFORMIN, THIAZOLIDINEDIONES, BLOOD sugar, DATABASES, DRUGS, LONGITUDINAL method, TYPE 2 diabetes, PRIMARY health care, RETROSPECTIVE studies, THERAPEUTICS
-
5دورية أكاديمية
المؤلفون: Bethel, M. Angelyn1 (AUTHOR), Stevens, Susanna R.2 (AUTHOR), Buse, John B.3 (AUTHOR), Choi, Jasmine4 (AUTHOR), Gustavson, Stephanie M.4 (AUTHOR), Iqbal, Nayyar4 (AUTHOR), Lokhnygina, Yuliya2 (AUTHOR), Mentz, Robert J.2 (AUTHOR), Patel, Rishi A.1 (AUTHOR), Öhman, Peter4 (AUTHOR), Schernthaner, Guntram5 (AUTHOR), Lecube, Albert6 (AUTHOR), Hernandez, Adrian F.2 (AUTHOR), Holman, Rury R.1 (AUTHOR)
المصدر: Circulation. 4/28/2020, Vol. 141 Issue 17, p1360-1370. 11p.
مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *TYPE 2 diabetes, *DRUGS, *PLACEBOS, *DIABETES complications, *STROKE prevention, *STROKE-related mortality, *STROKE, *MYOCARDIAL infarction, *BLOOD sugar, *HYPOGLYCEMIC agents, *RISK assessment, *LONGITUDINAL method, MYOCARDIAL infarction-related mortality
-
6دورية أكاديمية
المؤلفون: Pagidipati, Neha J.1 neha.pagidipati@dm.duke.edu, Navar, Ann Marie1, Pieper, Karen S.1, Green, Jennifer B.1, Bethel, M. Angelyn2, Armstrong, Paul W.3, Josse, Robert G.4, McGuire, Darren K.5, Lokhnygina, Yuliya1, Cornel, Jan H.6, Halvorsen, Sigrun7, Strandberg, Timo E.8,9, Delibasi, Tuncay10, Holman, Rury R.2, Peterson, Eric D.1, TECOS Study Group (CORPORATE AUTHOR)
المصدر: Circulation. 9/26/2017, Vol. 136 Issue 13, p1193-1203. 11p.
مصطلحات موضوعية: *CARDIOVASCULAR disease prevention, *PEOPLE with diabetes, *DIABETES, *ASPIRIN, *ACE inhibitors, *HYPOGLYCEMIC agents, *TYPE 2 diabetes complications, *ANGIOTENSIN receptors, *BLOOD pressure, *CARDIOVASCULAR diseases, *COMPARATIVE studies, *LONGITUDINAL method, *LOW density lipoproteins, *RESEARCH methodology, *MEDICAL cooperation, *TYPE 2 diabetes, *RESEARCH, *RESEARCH funding, *SMOKING, *LOGISTIC regression analysis, *EVALUATION research, *TREATMENT effectiveness, *PROPORTIONAL hazards models, *BLIND experiment, *DISEASE complications, *THERAPEUTICS, CARDIOVASCULAR disease related mortality, DISEASE relapse prevention
-
7دورية أكاديمية
المؤلفون: Becker, Frauke1 (AUTHOR), Dakin, Helen A.1 (AUTHOR) helen.dakin@ndph.ox.ac.uk, Reed, Shelby D.2 (AUTHOR), Li, Yanhong2 (AUTHOR), Leal, José1 (AUTHOR), Gustavson, Stephanie M.3 (AUTHOR), Wittbrodt, Eric3 (AUTHOR), Hernandez, Adrian F.2 (AUTHOR), Gray, Alastair M.1 (AUTHOR), Holman, Rury R.1,4 (AUTHOR)
المصدر: Diabetes Research & Clinical Practice. Jan2022, Vol. 183, pN.PAG-N.PAG. 1p.
مصطلحات موضوعية: *COST effectiveness, *TYPE 2 diabetes, *EXENATIDE, *GLUCAGON-like peptide-1 receptor, *HYPOGLYCEMIC agents, *COST benefit analysis, *QUALITY-adjusted life years, *LONGITUDINAL method
مصطلحات جغرافية: UNITED Kingdom
-
8دورية أكاديمية
المؤلفون: Agbaje, Olorunsola F.1 (AUTHOR) olorunsola.agbaje@dtu.ox.ac.uk, Coleman, Ruth L.1 (AUTHOR), Hattersley, Andrew T.2 (AUTHOR), Jones, Angus G.2 (AUTHOR), Pearson, Ewan R.3 (AUTHOR), Shields, Beverley M.2 (AUTHOR), Holman, Rury R.1 (AUTHOR), MASTERMIND consortium (CORPORATE AUTHOR)
المصدر: Diabetes Research & Clinical Practice. Aug2020, Vol. 166, pN.PAG-N.PAG. 1p. 3 Charts.
مصطلحات موضوعية: *TYPE 2 diabetes, *INDIVIDUALIZED medicine, *DURABILITY, *RESEARCH, *HYPOGLYCEMIC sulfonylureas, *COMBINATION drug therapy, *TIME, *RESEARCH methodology, *ARTHRITIS Impact Measurement Scales, *SULFONYLUREAS, *HYPOGLYCEMIC agents, *BLOOD sugar, *PROGNOSIS, *EVALUATION research, *MEDICAL cooperation, *INSULIN, *TREATMENT effectiveness, *COMPARATIVE studies, *RANDOMIZED controlled trials, *RESEARCH funding, *METFORMIN, *MEDICAL prescriptions, *LONGITUDINAL method